Dianthus Therapeutics, Inc.
USD98.13
+2.45 (+2.56%)
CEO
Marino Garcia
IPO Date
2018-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$96.50
Prev. Close
$95.68
Day Low
$95.22
Day High
$98.64
52W Low
$17.77
52W High
$98.69
Market Cap
$4.10B
Volume
0.57M
| -8.5 |
| 31 Dec 2023 | FY | 100.0% | -1541.2% | -25.8% | -24.3% | 0.00 | 18.42 | -1.2 |
| 31 Dec 2022 | FY | 100.0% | -443.8% | -38.7% | -34.3% | 0.01 | 9.97 | -0.8 |
| 31 Dec 2021 | FY | 100.0% | -888.1% | -7.6% | -6.9% | 0.00 | 16.63 | -18.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -52.1% | -46.4% | 0.00 | 13.26 | -4.6 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -54.4% | -47.5% | 0.00 | 10.62 | -7.3 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -39.5% | -36.6% | 0.00 | 13.95 | -3.3 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -70.5% | -65.2% | 0.00 | 12.68 | -14.5 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -104.3% | -83.2% | 0.00 | 4.71 | -54.5 |
| 4.0 |
| 30 Sept 2025 | Q3 | 100.0% | -9284.1% | -6.7% | -6.4% | 0.00 | 17.35 | -10.1 |
| 30 Jun 2025 | Q2 | 100.0% | -16388.1% | -10.4% | -9.7% | 0.00 | 13.12 | -5.3 |
| 31 Mar 2025 | Q1 | 100.0% | -2537.5% | -9.0% | -8.5% | 0.00 | 15.99 | -5.5 |
| 31 Dec 2024 | Q4 | 100.0% | -2144.8% | -8.1% | -7.6% | 0.00 | 15.22 | -6.7 |
| 30 Sept 2024 | Q3 | 100.0% | -1159.0% | -7.5% | -7.1% | 0.00 | 18.30 | -9.3 |
| 30 Jun 2024 | Q2 | 100.0% | -945.1% | -4.9% | -4.8% | 0.00 | 36.46 | -14.0 |
| 31 Mar 2024 | Q1 | 100.0% | -1573.0% | -3.7% | -3.6% | 0.00 | 42.52 | -13.9 |
| 31 Dec 2023 | Q4 | 100.0% | -2311.4% | -6.3% | -5.9% | 0.00 | 18.42 | -1.1 |